loader image
Monday, December 15, 2025
53.6 F
McAllen
- Advertisement -

Elevated Blood Sugar, Lower Gray Matter Volume Linked To Depression

Translate to Spanish or other 102 languages!

Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes
Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes

Medical News Today

- Advertisement -
  • An estimated 5% of all adults around the world live with depression. 
  • Fluctuations in a person’s blood sugar levels are a known risk factor for depression. 
  • Researchers from Sun Yat-sen University believe reduced gray matter volume in the brain may mediate the link between blood sugar levels and depression risk. 

About 5% of the entire world’s adult populationTrusted Source lives with depression — a mental disorder leaving a person feeling very sad and hopeless to the point where they do not enjoy their normal activities. 

There are quite a few risk factorsTrusted Source for depression, one of which is fluctuations in glycemia or a person’s blood sugar levels.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/elevated-blood-sugar-lower-gray-matter-volume-linked-to-depression

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Tips to Tame the ‘Sunday Scaries’

Weekends only last so long, and if you start feeling anxious by Sunday, you're not alone.

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

Off-the-Shelf Immunotherapy Offers Hope for Aggressive Myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. 

FDA Approves Zenflow Spring® System for BPH Treatment

 Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
- Advertisement -
×